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Abstract
Predialysis serum urea nitrogen and creatinine levels are not adequate gauges of hemodialysis
adequacy. Although far from being perfect, Kt/V and urea reduction ratio measurements are currently
in vogue. Control of blood pressure and maintenance of proper nutrition are of prime importance in
reducing morbidity and mortality among ESRD patients.
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Since a plethora of stellar publications pertaining to the
issue of urea kinetic modeling and adequacy of
hemodialysis is readily available (1-7), we will, instead,
attempt to highlight in this communication only certain
practical aspects of urea kinetic modeling that may be of
interest to dialysis professionals in their quest for better
management of patients suffering from end-stage renal
disease (ESRD).
Inadequacy of Predialysis Plasma Urea
Nitrogen (PUN) and Plasma Creatinine
Levels as Gauges for Adequate Dialysis
Therapy
How does one measure adequacy of dialysis treatments?
Is it how a patient feels? Does the presence or absence
of uremic manifestations determine whether a patient is
adequately dialyzed?
At first, one might be lured into believing that the
magnitude of predialysis PUN and plasma creatinine
values would serve as a satisfactory yardstick to evaluate
dialysis adequacy. Thus, satisfactory dialysis treatments
should, theoretically, result in reduction of PUN and
plasma creatinine values. However, it should be noted
that inadequate dialysis therapy can lead to the
occurrence of uremic symptoms of anorexia, nausea and
vomiting. As a consequence, the consumption of protein
is curtailed and the resultant decreased protein intake
can bring about a lowering of PUN concentrations (8).
Furthermore, the reduction of protein and other food
intake can bring about body wasting. As a result, dialysis
treatments that could not substantially lower PUN levels
previously (on account of a larger body mass) could do
so now. Accordingly, although a lower PUN level can
signify excellent dialysis, most of the time, however, such
a value represents underdialysis, body wasting and a
harbinger of early death. On the other hand, high PUN
levels are also often associated with high mortality risks
because such levels frequently represent underdialysis.
Therefore, both inordinately low and inordinately
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elevated PUN levels have been associated with high
mortality risks (9). With regard to body wasting and
plasma creatinine levels, a uremia-induced reduction in
protein intake can, over a period of time, cause body
wasting with a resultant loss of body muscle mass. Such
muscle mass attenuation can lead to reduced plasma
creatinine values (8). Not surprisingly, therefore, the
wasting of the body and its muscles is believed to be
responsible for the high mortality risks in patients with
low plasma creatinine values. In terms of high plasma
creatinine concentrations, however, although one would
ordinarily expect a high mortality risk with elevated
levels, the reverse is actually the case (9). This
observation may be related to the fact that high plasma
creatinine levels represent adequate muscle mass and
hence, good nutrition. This latter advantage may explain
the lower mortality risk in the face of high plasma
creatinine values. From the above description, therefore,
it is obvious that plasma levels of urea nitrogen and
creatinine are practically useless as guides to dialysis
adequacy (9).
Blood-side Urea Kinetic Modeling
Kt/V
In an attempt to provide a better measure of dialysis
adequacy, an index of dialysis, known as single-pool Kt/
V (i.e., spKt/V), has been proposed by Gotch and Sargent
(1,2). In this index, K represents plasma urea clearance
of the dialyzer in liters per minute; t, the duration of
dialysis in minutes; and V, the volume of distribution
for urea in liters. The value of Kt/V can be readily
obtained using a formal, blood-side, variable-volume,
computer-assisted urea kinetic modeling technique (1-
7). This method is based on the principle that during
dialysis, the PUN value falls logarithmically. The slope
of the logarithmic decline is represented by K/V (4). In
order to determine the slope, predialysis and postdialysis
measurements of PUN levels are required.
In an attempt to circumvent the use of complicated
mathematics in the derivation of spKt/V, various
relatively simple formulae have been devised. Of the
formulae currently proposed, the one championed by
Daugirdas (3,10), described below, is reasonably
accurate, widely used and readily handled by simple
calculators.
spKt/V = -ln(R - 0.008 x T) + (4 - 3.5 x R) x UF/W,
where ln = natural logarithm,
R = postdialysis single-pool PUN (spPUN)/
predialys is  PUN (the  "s ingle-pool"
designation means blood is obtained very
promptly after dialysis),
T = duration of dialysis in hours,
0.008 x T = correction factor for intradialytic urea
generation,
UF = ultrafiltrate volume obtained during
dialysis in liters,
and W = postdialysis weight in kilograms
However, blood-side urea kinetic modeling is fraught
with a myriad of blood-sampling problems. Such
problems include contamination by saline or heparin (7),
as well as the undesirable effects of access recirculation
(11,12), cardiopulmonary recirculation (11,13,14) and
urea rebound (15-18). To avoid dilution by saline or
heparin, predialysis blood samples should be collected
from a dry (saline-free and heparin-free) arterial needle
tubing prior to the initiation of dialysis. If the predialysis
blood sample is taken after proper dialysis has already
begun, the effects of access recirculation (should there
be any such recirculation) and of cardiopulmonary
recirculation, will lower the PUN level [when blood is
obtained from the proximal (from the patient's point of
view) blood sampling port of the arterial blood tubing]
(7,11-14).
To avoid the effects of any possible access recirculation,
the speed of the blood pump controlling the dialyzer
blood flow should be reduced to 50 mL/minute to100
mL/minute for 15 seconds prior to sampling from the
proximal sampling port of the arterial blood tubing (7).
Ordinarily, with any vascular access, should the access
inlet blood flow rate exceed that of the blood pump, any
just-dialyzed blood will find its way to the systemic
venous system via the venous limb of the access (Fig.
1). Should the access inlet blood flow rate be less than
that of the blood pump, a situation that can occur with
vascular obstruction (due to stenosis, for example, of
either the arterial or the venous limb of the access), a
volume of just-dialyzed blood equal to the difference
between the rate of the blood pump and that of the access
inlet blood flow, will be routed retrogradely to re-enter
the arterial blood line (Fig. 2,3) (11,12). To ensure that
access recirculation will not take place at the time of
postdialysis blood sampling, the blood pump rate should
be reduced to 50 mL/minute to 100 mL/minute, a rate of
blood flow that any clinically inadequate vascular access
is still capable of delivering (7) (the reason that this low
blood pump rate is maintained for 15 seconds prior to
blood sampling is to ensure that any access recirculation-
contaminated blood that might be present in the vicinity
of the proximal sampling port of the arterial blood tubing,
will have been displaced by incoming, fresh,
uncontaminated-by-access recirculation, systemic
arterial blood). Access recirculation, therefore, can best
be defined as 'the routing, in a retrograde fashion, of just-
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dialyzed blood emerging from the venous blood tubing,
into the arterial blood tubing and then into the dialyzer,
to be dialyzed again, without having the just-dialyzed
blood course through waste product-rich tissues first to
retrieve waste products' (11).
Cardiopulmonary recirculation, the other variety of
recirculation, occurs only during dialysis when using an
arteriovenous access but does not occur when using a
venovenous access (11,13).  Cardiopulmonary
recirculation can be defined as 'the routing of just-
dialyzed blood emerging from the venous blood tubing,
through the venous channels, the right heart, the lungs,
the left heart and the arterial channels, to return to the
arterial blood tubing and the dialyzer to be dialyzed again,
without having the just-dialyzed blood pass through waste
product-rich tissues first to retrieve waste products' (11).
Because of contamination by the just-dialyzed (hence
PUN-poor) blood in the above manner, arterial blood
always has a lower PUN concentration than venous blood
obtained from the central veins (11,13). However, after
the discontinuation of dialysis, equilibration of arterial
blood and central venous blood takes place promptly
within 2 to 3 minutes (7,13), resulting in an elevation of
arterial PUN levels. Being minor in magnitude except in
the face of hypotension (14) or, perhaps, in the presence
of heart failure, this cardiopulmonary recirculation-
induced effect on PUN levels is ignored in the above
postdialysis blood sampling method.
Another aspect in blood-side urea kinetic modeling that
merits discussion is the occurrence of postdialysis urea
Figure 1.  Normal hemodialysis circuit without stenosis of the arteriovenous access.
No access recirculation occurs because the access blood flow rate exceeds the blood
pump rate.
Figure 2.  In the face of arterial stenosis, access recirculation occurs when the blood
pump rate exceeds the access blood flow rate.
6Urea kinetic modeling
rebound (15-18). Urea rebound depicts the phenomenon
in which the PUN level rises rapidly before climbing at
a slower rate during the immediate postdialysis period.
Urea rebound is usually completed within 30 to 60
minutes following a dialysis treatment (15-18). Two
different theories, the diffusion theory and the perfusion
theory, have been advanced to elucidate the rebound
phenomenon. The diffusion theory suggests that during
dialysis, the intracellular levels of waste products remain
higher than their extracellular counterparts because of
delays in diffusion. After dialysis, equilibration of the
intracellular and extracellular levels takes place, thereby
accounting for the abrupt rise in extracellular values (4).
In contrast, the perfusion theory proposes that during
dialysis, certain vital tissues such as the brain, the heart,
the lungs and the other viscera do receive proportionally
more blood flow than other less vital tissues such as the
muscles, the bones, the fat and the skin. Because of the
lower blood flow rates, removal of waste products from
these latter low-flow areas by dialysis is hampered. After
completion of dialysis, however, the disparity in blood
flow rates is abolished and those waste products
sequestered in previously low-flow areas can now readily
enter the general circulation, thus accounting for the
phenomenon of urea rebound (19). Irrespective of the
exact mechanism involved in the causation of urea
rebound, however, the effects of such a rebound on
postdialysis PUN levels are considerable.
The previously described method of postdialysis blood
sampling, recommended by the Dialysis Outcome
Quality Initiative (DOQI) Clinical Practice Guidelines
Figure 3.  In the face of venous stenosis, access recirculation occurs when the blood
pump rate exceeds the access blood flow rate.
Figure 4.  Postdialysis blood specimen should be obtained from the proximal sampling
port after the blood pump rate has been reduced to 50 mL/minute to 100 mL/minute for
15 seconds. This slow-flow method ensures that the blood so obtained is fresh arterial
blood and devoid of access recirculation-contaminated blood.
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of the National Kidney Foundation, USA, does not take
the phenomenon of urea rebound into consideration.
When blood sampling is carried out after urea rebound
is complete, the postdialysis PUN so obtained is known
as an equilibrated PUN (ePUN) while the Kt/V value
obtained when ePUN is utilized for its derivation [e.g.,
substituting ePUN for postdialysis spPUN during
computation of R in Daugirdas' formula (vide supra)] is
termed an equilibrated Kt/V (eKt/V). One way to obtain
ePUN is to collect blood 30 minutes after the end of
dialysis from the proximal sampling port of the arterial
blood tubing using the slow-flow technique mentioned.
On the other hand, it has recently been shown that the
PUN level obtained 30 minutes prior to the end of dialysis
is similar to the value obtained 30 minutes after the end
of dialysis (20-22). This "30-minutes prior" method of
obtaining ePUN and eKt/V would appear more practical
than the "30-minutes post" approach since it is difficult
to require a patient to stay for an extra 30 minutes after a
dialysis session is over.
Alternatively, eKt/V can be derived from spKt/V by the
use of formulas without obtaining an ePUN level (23-
28). An example of such an approach is as follows (24,
25): When using an arteriovenous access:
eKt/V = spKt/V - 0.60(spKt/V)/T + 0.03,
where eKt/V = equilibrated Kt/V,
spKt/V = unequilibrated, single-pool Kt/V,
T = treatment time in hours.
When using a venovenous access (e.g., a venous
catheter), because of the absence of cardiopulmonary
recirculation, the formula becomes:
eKt/V = spKt/V - 0.47(spKt/V)/T + 0.02
Having a value smaller  than that  of  spKt/V
[approximately 0.24 smaller in value for a regular
treatment (28)], eKt/V has been suggested to be a more
accurate measure of dialysis adequacy than its single-
pool, unequilibrated counterpart. This is especially true
in the case of rapid dialysis (17) or in the instance of
children (23) or small adults being dialyzed with highly
efficient dialyzers perfused with high blood and dialysate
flow rates. It should be realized that any Kt/V calculations
using predialysis and postdialysis PUN levels are, under
certain circumstances, affected by changes in the urea
generation rates as well as consequent changes in V
during the course of dialysis (29-31). For example, urea
generation rate is raised with intradialytic parenteral
nutrition; as a result, the magnitude of V increases,
causing a reduction in the Kt/V value (if K and t remain
constant) (31). In addition, V values may also become
small during highly efficient and short dialysis treatments
(32,33).
Urea Reduction Ratio
The urea reduction ratio (URR) (34), a gauge of urea
removal, is obtained by:
[(Predialysis PUN - Postdialysis spPUN)/Predialysis PUN]
x 100%
This value does not take the effects of ultrafiltration and
of intradialytic urea generation into account. Therefore,
it is a less accurate measure of dialysis adequacy than
Kt/V. However, in case Kt/V values are unavailable,
URR results are acceptable substitutes. A simple
monogram for calculating Kt/V from URR and
ultrafiltration rate is available (7,35). Finally, the use of
equilibrated URR (eURR), the counterpart of eKt/V and
obtained by substituting postdialysis spPUN with ePUN,
has recently been suggested (36).
How Much Kt/V, eKt/V or URR Is Enough?
In order to achieve adequate dialytic therapy using
conventional, thrice-weekly hemodialysis treatments,
DOQI recommends a spKt/V value of not less than 1.2
[extrapolating to an eKt/V of not less than 1.0 (28)] and
a URR of not less than 65% (5,7). The suggestion is often
made, however, that a spKt/V value of 1.3 (extrapolating
to an eKt/V of 1.1) should be targeted in order to make
allowance for any possible inadvertent inadequacy in
dialysis delivery (7). This latter recommendation is
especially applicable for centers that practice reuse since
reuse is commonly associated with reductions in dialyzer
clearance of certain solutes (37,38). Noteworthy is the
fact that, in the USA, patient mortality risk is lowered
by 7% for each 0.1 increment in delivered spKt/V up to
a level of 1.3, and by 11% for each 5% increment in
delivered URR up to a value of 70% (39). Whether further
reductions in mortality rates can be obtained in the USA
once spKt/V and URR values exceed 1.3 and 70%
respectively is at present unknown (39). In this respect,
it should be noted that Charra et al in Tassin, France,
were able to achieve a stellar survival rate of 87% at 5
years and 43% at 20 years when the delivered spKt/V
value averaged 1.67 (40). (Since only 9% of Charra's
patients were diabetic, one would ordinarily expect
survival rates to be better than average, but certainly not
to this spectacularly outstanding degree). The reason why
Charra's patients fared so much better than those from
other centers is at present poorly understood. The
suggestion has been made that, although the spKt/V
results of Charra's patients were exemplary, the superior
blood pressure control  (98% of the pat ients
were normotensive without the need to receive
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antihypertensive medications), a consequence of optimal
fluid removal made possible by prolonged dialysis, was
most likely a major factor for the impressive survival
results (40). In this regard, it cannot be overemphasized
that the proper control of blood pressure is of paramount
importance in reducing mortality and morbidity in ESRD
patients.
Lending support to Charra's results, a recent survey by
the Japanese Society for Dialysis Therapy suggested that
mortality risks would continue to decrease until Kt/V
values reached 1.8 (41). Furthermore, the risk of
hospitalization has been shown to be greater in patients
whose Kt/V was less than 1.4, compared to those whose
Kt/V was higher (42). When interpreting the above
Japanese data, it should be reminded that on account of
a variety of reasons such as body build, race, genetic
makeup, diet, etc., mortality risks for certain Asian
dialysis patients have been found to be lower than those
for many non-Asian counterparts (43).
Recently, it has come to light that the risk of death in
hemodialysis patients levels off or even increases slightly
when URR exceeds approximately 70% (i.e., spKt/V
greater than 1.3)(44). Such an effect on mortality risk
may be related to the following: (a) malnutrition which
can lead to a smaller body mass and, hence, a lower V
and a higher Kt/V (in the face of a given Kt, a reduced V
will engender a high Kt/V value); and/or (b) failure of
proper management of acid-base or electrolyte
imbalances that can result from poorly executed, but,
nevertheless, still intensive dialysis treatments.
Finally, it should be noted that dialyzing patients
aggressively for short periods of time heightens the
magnitude of urea rebound and magnifies the deviation
of spKt/V values from eKt/V estimations. The suggestion
has been made that in order to ensure adequate dialysis
delivery when performing high-efficiency dialysis, the
target spKt/V should be raised by an average of 0.2 for
treatments that last less than 3.5 hours (17).
It should be realized that, prior to DOQI, there had never
been any universally accepted guidelines for the
collection of predialysis and postdialysis blood samples.
A variety of publications describing Kt/V results did not
specifically disclose clearly their methods of blood
collection. However, even if the techniques employed
were announced, various authors utilized dissimilar
approaches. In this respect, a recent large-scaled study
has revealed that 25% of dialysis units surveyed did not
take the possible existence of access recirculation into
consideration in their postdialysis blood sampling
techniques (45). Furthermore, the United States Renal
Data System Dialysis Morbidity and Mortality Study
Wave I discovered a wide variation in postdialysis blood
sampling methods among the nation's dialysis units;
14.6% immediately without any period of "slow flow",
47.7% immediately after slowing or stopping blood flow,
9.3% within 20 to 60 seconds of "slow flow" and 28%
Figure 5.  Partitioning of spent dialysate into a large main fraction and a much smaller
representative fraction (the present figure is modified from a diagram previously
published in reference 56; permission for the modification has been granted by the
publisher).
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within 1 to 15 minutes of "slow flow" (46).
Because of this lack of uniformity in blood sampling
techniques, the Kt/V results obtained from various units
could not be subjected to vigorous statistical analysis.
Therefore, recent assertions based on national or
international surveys that purported to correlate clinical
outcomes with Kt/V data should be regarded with caution
(47). It cannot be overemphasized that standardization
of sampling techniques is essential not only for the
accurate determination of dialysis adequacy in an
individual patient but also for the provision of meaningful
data that could be statistically analyzed in the course of
determination of dialysis adequacy among patients, units
and clinical trials (45).
To summarize, the jury is still out with respect to the
ideal Kt/V or URR levels for which one should strive.
We believe that values should certainly not be allowed
to fall below those recommended by DOQI guidelines.
Experiences in both France and Japan suggest that
spKt/V values higher than 1.2 (such as 1.6 to 1.8) are
quite beneficial.
Dialysate-side Urea Kinetic Modeling
The purpose of dialysis is to remove waste products from
the body. One approach to evaluate whether a particular
dialysis treatment is adequate is to determine exactly how
much urea or some other waste product(s) is lost into
the dialysate and, hence, disposed from the body. Direct
quantification of urea removed in the course of dialysis
has long been regarded as the gold standard by which
other methods of urea modeling are judged (48).
There are various methods to accomplish dialysate-side
urea modeling, viz., those involving measurement of urea
in total dialysate (48), partial dialysate (49-52) or serial
samples of dialysate (53-55). Collection of the total
volume of spent dialysate derived from a single dialysis
session is a laborious and seldom practiced process (48).
Serially measuring dialysate urea level using an on-line
urea monitor appears to be a promising undertaking (54);
however, a major drawback of the technique is the high
cost of the equipment involved. We prefer the use of a
partial dialysate collection method in which a
representative sample of the total spent dialysate is
retrieved (50,56-58). The total amount of urea removed
by a dialysis treatment is derived by the product of the
urea level in the representative sample and the volume
of the total spent dialysate [this volume is obtained by
the product of the dialysate flow rate (readily displayed
by most modern dialysis machines) and the duration of
dialysis]. In this partial dialysate collection method, a
side-tube is inserted into the dialysate drainage tube using
a T-connector (Fig. 5). The open end of the side-tube is
capped with a 22- or 24-gauge plastic needle. An
adjustable clamp is placed on the dialysate drainage tube
at a site distal to the T-connector so that an uninterrupted
stream of spent dialysate can be collected via the plastic
needle into a receptacle. The rate of outflow from the
needle can be in the order of 5 mL/minute or thereabouts.
Once this partial dialysate collection process begins, one
should refrain from manipulating the adjustable clamp
and from placing any other pressure on the dialysate
drainage tube. Similarly, the side-tube should be free
from external compression during the collection
procedure. To ensure that breakdown of urea due to
bacterial multiplication in the collected dialysate does
not occur, one can surround the receptacle with ice to
minimize bacterial growth.
There are various approaches to calculate Kt/V using
dialysate collection methods (48,53,54). However, many
of these methods are cumbersome and difficult to
perform. At present, we believe that dialysate-side urea
monitoring is still in the developmental stage. The future
role of such monitoring in assessing dialysis adequacy
is still unknown.
Recently, a new approach of dialysate-side solute
monitoring (50,59,60) has been described. The method,
employing what is known as the Solute Removal Index
(SRI), is as follows:
SRI = 100% x net solute removal/Predialysis
body content of solute.
= 100% x [amount of urea removed during dialysis
-amount of urea generated during dialysis]/
Predialysis body content of urea.
When knowledge about the amount of urea generated
during dialysis is not available, the following index,
termed by us as the Simplified Solute Removal Index
(SSRI), becomes applicable (50,61).
SSRI = 100% x solute removal/Predialysis body content
of solute
= 100% x amount of urea removed during dialysis/
Predialysis body content of urea.
At present, the role of SRI and SSRI in assessing dialysis
adequacy remains to be determined.
Protein Catabolic Rate (or Protein Nitrogen
Appearance Rate) and Nutrition
An important facet in the proper management of the
ESRD patient is the provision of adequate nutrition. In
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stable patients who are at a steady state and, therefore,
by inference, in nitrogen balance, net protein catabolism
is equal to protein intake. Because of this relationship,
protein intake can readily be gauged by determination
of the net protein catabolic rate (PCR) in stable dialysis
patients. Since urea is a by-product of protein breakdown,
PCR can be assessed either by gauging the increment in
PUN concentrations during the interdialytic period using
formal urea kinetic modeling (1-7), or it can be
determined more reliably by direct measurement of the
quantity of urea removed by dialysis (62). Garred et al
recommends the following approach (62):
nPCR = CU/BW + 0.17,
where nPCR = normalized PCR (PCR normalized to
weight), g protein/kg/day.
U = the number of grams of urea nitrogen
removed by dialysis during the first,
midweek or final dialysis of the week (for
patients undergoing thrice-weekly dialysis
treatments),
C = 2.45, 2.89, or 3.10, respectively,
BW = patient's postdialysis dry weight in
kilograms
Again, the amount of urea removed by dialysis can be
obtained by various dialysate sampling or monitoring
methods above-mentioned.
It cannot be overemphasized that proper nutrition is part
and parcel of any appropriate therapy for a dialysis
patient. Therefore, a satisfactory normalized PCR (i.e.,
dietary protein intake) in the order of at least 1.0 g/kg
to1.2 g/kg body weight/day should be one's goal (63,
64). In this regard, Owen et al have found that mortality
rate in hemodialysis patients is inversely related to
plasma albumin values and the URR. This suggests that
the more satisfactory the dialysis therapy and the better
the nutrition (as reflected by plasma albumin values),
the lower the mortality rate (34). In the same vein, Linsay
et al have shown that the better the spKt/V value, the
higher the normalized PCR (65). Furthermore, raising
dialysis dosage from a URR of 58% to one of 70% has
been found to raise serum albumin values (66). It is
generally believed that, up to a certain point, adequate
dialytic therapy can engender a better appetite with a
resultant higher food consumption, thereby improving
nutritional status.
Residual Renal Function
In the evaluation of dialysis adequacy using the Kt/V
approach, we prefer not to take residual renal function
into consideration. We regard the contribution of residual
renal function to the overall disposal of waste products
from the body as a therapeutic bonus.
Vigilance for Dialysis-associated
Complications
In our quest for optimal dialytic therapy, it behooves us
to be vigilant of potentially life-threatening electrolyte
and acid-base imbalances that can occur in dialysis
patients. For example, because of the intensive dialysis
treatments, plasma bicarbonate concentrations may be
inadvertently elevated if one fails to adjust dialysate
bicarbonate levels in accordance with each individual
patient's needs. In addition, intensive dialysis can
occasionally bring about hypophosphatemia (67),
especially in malnourished and emaciated patients and
in the presence of phosphate-binder therapy, intravenous
fluid administration or parenteral nutrition therapy (68).
Apart from correcting hypophosphatemia with the use
of oral and/or intravenous phosphate therapy, one can
treat or prevent this electrolyte abnormality by using a
phosphorus-enriched dialysate (67,69). Finally, plasma
potassium levels should also be closely monitored in
aggressively dialyzed patients.
Future Possibilities
Although blood-side solute monitoring is at present in
vogue, dialysate-side monitoring involving urea or other
solutes may play a role in the future. For example, use
of dialysate-side chemistry or conductivity data, in the
presence or absence of blood-side values, to derive
dialyzer urea or electrolyte clearance to gauge dialysis
adequacy has been recommended (70,71). The recently
proposed concept of "equivalent renal urea clearance"
obtained by dividing the urea generation rate by the time-
averaged urea level does warrant further investigation
(7 2). Finally, the recent resurgence of the daily or nightly
dialysis technique (69,70,73) may require new insights
and modifications in solute monitoring. Additionally, the
use of these techniques has been rewarded with a better
control of blood pressure (69,70,73).
* Modified and updated from an article in Chinese entitled
"Quality of Dialysis 1997" and published by Excerpta
Medica Asia Ltd. Permission to publish this version has been
granted by the above publisher.
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